Researchers discovered an alternative way to classify distinct types of colon cancer, making the information more valuable to patients and their doctors as they consider treatment.
Aug 23, 2024
0
2
A molecule called nidogen-2 may be a key driver of pancreatic cancer progression and metastasis, offering a promising new treatment approach for this aggressive cancer, according to a Garvan Institute study.
Jul 8, 2024
0
52
Scaling back treatment for three kinds of cancer can make life easier for patients without compromising outcomes, doctors reported at the world's largest cancer conference.
Jun 2, 2024
1
99
Since 2004, several clinical studies have reported that patients with OXA frequently experienced adverse effects of liver injury (LI), typically characterized by hepatic sinusoidal injury, splenomegaly, decreased platelet ...
Feb 8, 2024
0
0
As the United States faces a growing obesity epidemic, scientists are taking a closer look at how body weight can affect health outcomes. New research published in Blood Advances highlights the potential association of elevated ...
Jul 13, 2023
0
2
Nationwide shortages of two dozen chemotherapy drugs are leading to rationing and delays in treatment for cancer patients, local and national authorities say.
May 22, 2023
0
4
Among people receiving chemotherapy regimens containing anthracyclines for lymphoma, those who took the cholesterol-lowering drug atorvastatin for one year were significantly less likely to show evidence of heart dysfunction ...
Mar 6, 2023
0
4
A four-drug chemotherapy regimen provided longer overall survival than a two-drug combination in a Phase 3 clinical trial for metastatic pancreatic ductal adenocarcinoma. The study is believed to be the first metastatic pancreatic ...
Jan 20, 2023
0
5
While children receiving chemotherapy routinely undergo hearing tests, adults don't, and a new study by UC San Francisco reports for the first time that significant hearing issues often occur among adult survivors of the ...
Jul 27, 2022
0
15
There is considerable variation in the management of mantle cell lymphoma across different clinical settings, and some strategies do not always conform with what might be expected, according to an analysis by investigators ...
Jun 28, 2022
0
5
A fundamental philosophy of combination cancer therapy is that different drugs work through different cytotoxic mechanisms. Because they have different dose-limiting adverse effects, they can be given together at full doses in chemotherapy regimens.
The term "induction regimen" refers to a chemotherapy regimen which is used for the initial treatment of a disease.
Chemotherapy regimens are often identified by acronyms, identifying the agents used in combination. However, the letters used are not consistent across regimens, and in some cases (for example, "BEACOPP") the same letter combination is used to represent two different treatments: there is not a naming standard for chemotherapy regimens. This page merely lists commonly used conventions.
This text uses material from Wikipedia licensed under CC BY-SA
